2.73
2.73 (-0.26%)
As of Mar 06, 2024
Immutep Ltd [IMMP]
Source:
Company Overview
Immutep Ltd. is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism.
| Country | United States |
| Headquarters | sydney |
| Phone Number | 61 2 8315 7003 |
| Industry | manufacturing |
| CEO | Marc Voigt |
| Website | www.immutep.com |